Video Archives

Guidance on Troubleshooting Urostomy Management

Posted by Terran W. Sims, NP, MSN, ACNP-C, CNN, COCN-C | Aug 2024

Terran W. Sims, MSN, ACNP-C, CNN, COCN-C, provides comprehensive guidance on troubleshooting urostomy management, addressing the challenges faced by healthcare providers and patients. Her analysis focuses on practical strategies and evidence-based practices to optimize patient outcomes and improve the quality of life for those with urostomies.

Sims highlights the common complications associated with urostomies, such as skin irritation, stoma retraction, prolapse, and infections. She also discusses the selection of appropriate urostomy appliances.

Patient education is a cornerstone of Sims’s approach, underscoring the significance of empowering patients with the knowledge and skills necessary to manage their urostomies independently. Furthermore, Sims examines innovative solutions and emerging technologies that can enhance urostomy management, such as advanced wound care products and telehealth services.

Streamlining Management of the Neurogenic Patient Population with or without Incontinence

Posted by Mikel L. Gray, PhD, FNP, PNP, CUNP, CCN-AP, FAANP, FAAN | Aug 2024

Mikel L. Gray, PhD, FNP, PNP, CUNP, CCN-AP, FAANP, delves into the management of neurogenic bladder dysfunction, with or without incontinence. He emphasizes the necessity for a comprehensive, multidisciplinary approach that integrates the latest advancements in diagnostics, therapeutics, and patient education to optimize clinical outcomes and enhance quality of life.

A focal point of Dr. Gray’s discourse is the importance of individualized care plans. Dr. Gray highlights the integration of pharmacological treatments, such as anticholinergics and beta-3 agonists, which are pivotal in managing symptoms of neurogenic bladder dysfunction. Additionally, he advocates for non-pharmacological interventions, including pelvic floor muscle training and neuromodulation therapies.

Looking ahead, Dr. Gray addresses emerging technologies and potential advancements in regenerative medicine. He highlights ongoing research and development efforts aimed at creating more effective and less invasive treatments, which could revolutionize care practices in the near future.

Chronic Catheter Patients Made Simple

Posted by Mikel L. Gray, PhD, FNP, PNP, CUNP, CCN-AP, FAANP, FAAN | Aug 2024

Mikel L. Gray, PhD, FNP, PNP, CUNP, CCN-AP, FAANP, addresses the complexities of managing chronic catheter patients, offering insights and strategies to simplify their care. He discusses the types of catheters commonly used in chronic care, including indwelling urethral catheters, suprapubic catheters, and intermittent catheters, highlighting the indications for each type and providing guidance on selecting the most appropriate catheter based on individual patient needs and conditions.

Dr. Gray underscores the critical importance of infection prevention and best practices for catheter insertion and maintenance. He discusses the role of antimicrobial catheters and the appropriate use of prophylactic antibiotics in reducing infection rates and addresses the causes of catheter blockages.

Competing Risks for Small Renal Masses

Posted by Jeremy Slawin, MD, MBA | Aug 2024

Jeremy Slawin, MD, MBA, addresses competing risks in managing small renal masses (SRM), balancing treatment versus active surveillance of low risk disease. He begins by illustrating the characteristics of SRMs.

Dr. Slawin recognizes the low metastatic potential of SRMs. In combination with their average slow growth rate, SRMs under 3cm often do not need intervention beyond surveillance.

Dr. Slawin concludes by comparing the 5-year survival rates of patients with SRM versus all other causes. He offers online tools, like the RCC Competing Risk Model, and framing techniques to help clinicians effectively communicate the risks of SRM treatments to individual patients.

Therapeutic Modalities for BPH

Posted by Brian T. Helfand, MD, PhD | Aug 2024

Brian T. Helfand, MD, PhD, explores therapeutic modalities to prevent non-compliance in patients with Benign Prostatic Hyperplasia (BPH). He begins by establishing the pattern of medication-based non-compliance in BPH patients due to the impact on sexual function, and the evolution of BPH management.

Dr. Helfand then discusses recent technologies for BPH management which preserves sexual function. He presents current options for surgical intervention for BPH ranging from minimally-invasive surgical therapies to prostatectomies. For each option, he explores the treatment’s durability and impact on quality of life.

Dr. Helfand concludes by presenting resources to help urologists and patients choose the most appropriate treatment modality for their individual cases. He emphasizes the importance of involving the patient in the decision-making process in order to ensure compliance.